Low-intensity pulsed ultrasound (LIPUS) stimulation has been shown to increase the expression of brain-derived neurotrophic factor (BDNF) in astrocytes of an in vitro model and rat brains of an in vivo model; however, their molecular mechanisms are still not well clarified. Here, we investigated the underlying mechanisms of BDNF enhancement by LIPUS in rat cerebral cortex astrocytes. After LIPUS stimulation in astrocytes, the protein and mRNA expressions were measured by western blot and RT-PCR, respectively. The concentration of intracellular calcium was determined spectrophotometrically. The results showed that LIPUS enhanced the phosphorylation of tropomyosin-related kinase B (TrkB) and Akt but had no effect on Erk1/2 phosphorylation. Additionally, LIPUS increased the intracellular concentration of calcium and enhanced the protein levels of calmodulin-dependent kinase (CaMK) II and CaMKIV. LIPUS also activated the phosphorylation of NF-κB-p65 but did not promote the activation of cAMP response element-binding protein (CREB). Taken together, our results suggest that LIPUS stimulation upregulates BDNF production in astrocytes through the activation of NF-κB via the TrkB/PI3K/Akt and calcium/CaMK signaling pathways. BDNF has emerged as a major molecular player in the regulation of neural circuit development and function. Therefore, LIPUS stimulation may play a crucial and beneficial role in neurodegenerative diseases.
Introduction
Brain-derived neurotrophic factor (BDNF) is the most prevalent neurotrophin in the central nervous system (CNS). It is essential to the development and maintenance of normal neuronal circuits in the brain. Because BDNF plays a key role in the plasticity of the brain, it is widely implicated in neurodegenerative and psychiatric diseases (Nagahara and Tuszynski 2011; Lu et al. 2013) . Physical activity has been shown to promote the mRNA expression of BDNF in the brain (hippocampus and caudal cortex), which could enhance the brain's resistance to damage and degeneration (Neeper et al. 1995 (Neeper et al. , 1996 . BDNF not only enhances the growth and differentiation of the nerve cells but also improves cognitive dysfunction, so it has become a major focus of biomedical research in the pathogenesis of neurodegenerative disorders.
The efficacy of exogenous BDNF for the treatment of neuronal disorders was limited due to its blood-brain barrier (BBB) impermeability and short half-life in the systemic circulation. Focused ultrasound (FUS)-induced BBB disruption could be a noninvasive tool for delivering BDNF into the brain (Baseri et al. 2012; Huang et al. 2012) . However, acquiring BDNF is likely to be fairly expensive, and exogenous BDNF may also have side effects such as a pro-epileptic effect (Koyama and Ikegaya 2005) . Low-intensity pulsed ultrasound (LIPUS) has been shown to enhance endogenous BDNF expression in cerebral cortex astrocytes and osteoblastic cells (Hou et al. 2009 ). Recently, LIPUS has been shown to induce neuroprotective effects against AlCl 3 -induced cerebral damage and cognitive dysfunction by increasing neurotrophic factor protein levels . These findings suggested that the enhancement of endogenous BDNF via LIPUS stimulation could represent a novel technique for treating patients with CNS disorders.
Tropomyosin-related kinase B (TrkB) is activated by binding to BDNF, which activates the downstream signals of Akt, extracellular signal-regulated kinase (Erk), or phospholipase C-γ (PLC-γ) through receptor autophosphorylation and dimerization. Both the BDNF/TrkB and calcium/calmodulin-dependent kinase (CaMK) pathways are considered responsible for the activation of the transcription factor cAMP response element-binding protein (CREB), which results in gene expression of BDNF and is involved in the development of synaptic plasticity (Lonze and Ginty 2002) . Furthermore, the activation of nuclear factor-κB (NF-κB) has also been shown to be involved in the expression of neurotrophic factors. The specific phosphorylation of NF-κB by CaMKIV increases NF-κB-driven gene transcription (Bae et al. 2003) . Increasing evidence has shown that the expression of BDNF is modulated by neuronal activity accompanying the influx of Ca 2+ into neurons (Bading et al. 1993; Tsuda 1996) . In addition, it has been shown that intracellular calcium signaling is involved in the LIPUS-stimulated chondrocyte matrix proteoglycan synthesis, which would be associated with accelerated fracture healing (Parvizi et al. 2002 ). An increase in intracellular calcium concentrations can be observed within seconds of exposure to ultrasound. Ca 2+ ions constitute a universal signaling mechanism in the CNS, but they play different roles in neurons and astrocytes. One study has indicated, for example, that astrocytes lack the intracellular Ca 2+ signal pathways required to activate CREBdependent gene transcription in neurons (Murray et al. 2009) . From this point of view, it is crucial to determine whether LIPUS affects the expression of BDNF in astrocytes through intracellular Ca 2+ and the BDNF/TrkB signal pathway. Therefore, in this study, we hypothesized that LIPUS would stimulate BDNF expression through the BDNF/TrkB and Ca
2+
/CaMK signaling pathways in cerebral cortex astrocytes. We designed experiments to determine whether or not LIPUS could promote the phosphorylation of TrkB and Akt, enhance the intracellular concentration of Ca 2+ , stimulate the expressions of CaMKII and CaMKIV, and subsequently activate CREB or NF-κB for BDNF protein expression in cultured rat cerebral cortex astrocytes.
Materials and Methods

Ultrasound Equipment
The LIPUS stimulation was prepared as described previously . In in vitro experiments, the LIPUS was generated by a 1-MHz plane piezoelectric transducer (A394S-SU, element diameter = 29 mm; Panametrics, Waltham, MA, USA) with 50 ms burst lengths at a 50% duty cycle and a repetition frequency of 10 Hz. The spatial-peak temporal-average intensities (I SPTA ) over the plane transducer head was 110 mW/cm 2 and
was measured with a radiation force balance (RFB, Precision Acoustics, Dorset, UK) in degassed water. LIPUS was transmitted from the plane transducer to the bottom of the cell culture plate. US transmission gel (Pharmaceutical Innovations, Newark, NJ, USA) was used to cover the area between the transducer and the plate to maximize the transmission of the ultrasound. Each sample of astrocyte cells was treated with multiple LIPUS stimulations by triple sonication. The duration of each sonication was 5 min, and there was an interval of 5 min between the first and second and between the second and third sonications. The total sonication time of LIPUS stimulation was 15 min.
Cell Cultures
A rat astrocyte cell line (CTX TNA2) was obtained from the Bioresource Collection and Research Center (BCRC, Hsinchu, Taiwan). The CTX TNA2 cell line was established from primary cultures of type 1 astrocytes from brain frontal cortex tissue of 1-day-old rats. The cells were grown on a 6-well plate in 95% air-5% CO 2 with Dulbecco's modified Eagle's medium (DMEM; Gibco, New York, NY, USA), which was supplemented with 10% fetal bovine serum (FBS; Biological industries, Kibbutz Beit Haemek, Israel), penicillin (100 U/mL), and streptomycin (100 μg/mL) (Gibco, New York, NY, USA) ( pH adjusted to 7.6) (Lin et al. 2014) . Two different cell densities were prepared for subsequent experiments: a cell density of 1 × 10 5 cells/well for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, and a cell density of 1 × 10 6 cells/well for western blotting analysis. The following antibodies and agents were used in cell culture experiments: rabbit polyclonal antibodies specific for BDNF, p-TrkB, TrkB, p-NF-κB p65 (ser536), and NF-κB p65 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal antibodies specific for c-Fos, p-Akt (ser473), Akt, p-Erk1/2, Erk1/2, CaMKII, CaMKIV, p-CREB (ser133), and CREB were purchased from Cell Signaling Technology (Beverly, MA, USA). Akt inhibitor (MK2206) and NF-κB inhibitor (QNZ) were purchased from Selleck Chemicals (Houston, TX, USA).
Western Blotting Analysis
Astrocytes were incubated at 0, 0.5, 1, 2, 4, 8, 12, and 24 h after multiple LIPUS stimulations. The astrocytes were washed in cold PBS and lysed for 30 min on ice with T-Per extraction reagent (Pierce Biotechnology, Inc., Rockford, IL, USA). Lysates were centrifuged and the supernatants were harvested, and protein concentrations were assayed with Protein Assay Reagent (Bio-Rad, Hercules, CA, USA). Samples containing 30 μg of protein were resolved on 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Immun-Blot polyvinyldifluoride (PVDF) membranes (Bio-Rad). After blotting, the membranes were blocked for at least 1 h in blocking buffer (Hycell, Taipei, Taiwan), and then the blots were incubated overnight at 4°C in a solution with primary antibodies raised in rabbit against BDNF (1:250), TrkB, p-TrkB, Akt, pAkt, Erk1/2, p-Erk1/2, PLCγ, CaMKII, CaMKIV, CREB, and NF-κB (1:1000). After being washed with PBST buffer, the membrane was incubated with the secondary antibodies for 1 h at room temperature. After being washed with PBST buffer, signals were developed using a Western Lightning ECL reagent Pro (Bio-Rad). Western blot signals were analyzed and visualized using an ImageQuant LAS 4000 biomolecular imager (GE Healthcare Bio-Sciences AB, Sweden).
Quantitative Real-Time PCR
Cells were collected and their mRNA expression was detected by Bio-Rad iQ5 Real-time RT-PCR Detection System. Total RNA was extracted from astrocytes using a TRIzol kit (MDBio Inc., Taipei, Taiwan). The reverse transcription reaction was performed using 1 μg of total RNA that was reversely transcribed into cDNA using a commercial kit (Invitrogen, Carlsbad, CA, USA). PCR was performed using an initial step of denaturation (5 min at 94°C), 28-34 cycles of amplification (94°C for 30 s, 55°C for 30 s, and 72°C for 30 s), and an extension (72°C for 5 min). PCR products were analyzed on 2% agarose gels and stained with ethidium bromide. The mRNA of β-actin served as the internal control for sample loading and mRNA integrity. The primer sets of BDNF (forward: 5′-CAGGGGCATAGACAAAAG-3′; reverse: 5′-CTT CCCCTTTTAATGGTC-3′), c-Fos (forward: 5′-AGCATGGGCTCCCC TGTCA-3′; reverse: 5′-GAGACCAGAGTGGGCTGCA-3′), and β-actin (forward: 5′-CCTGTATGCCTCTGGTCGTA-3′; reverse: 5′-CCATCTC TTGCTCGAAGTCT-3′) were used.
Intracellular Calcium Measurement
The Ca 2+ concentration in the cleared lysate was determined spectrophotometrically using a Calcium Detection Kit (Biovision, Milpitas, CA, USA). In the experiment of calcium chelation, astrocytes were pretreated with 1,2-bis(2-aminophenoxy) ethane-N,N, N′,N′-tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM) (Tocris Bioscience, MO, USA) for 40 min followed by stimulation with LIPUS for 15 min.
Statistical Analysis
All data are expressed as means ± SEM. Statistical analysis was performed using an unpaired Student t-test. The level of statistical significance was set at a P value of ≤0.05.
Results
LIPUS Increases the Expression of BDNF in Cerebral Cortex Astrocytes
To confirm the effects of LIPUS on astrocyte growth and BDNF expression, the methods of MTT assay and western blotting and quantitative real-time PCR (qPCR) were used. The effect of LIPUS stimulation on the growth of astrocytes was evaluated (Fig. 1A) . The increase in cell growth was significantly higher in astrocytes subjected to LIPUS stimulation within 24 h than in control cells (Fig. 1A) . The effect of LIPUS stimulation on the BDNF expression in astrocytes was also tested (Fig. 1B,C) . The results of western blotting and qPCR showed that LIPUS significantly increased the mRNA and protein levels of BDNF in a time-dependent manner (Fig 1B,C) . This finding is consistent with a previous study that has demonstrated increasing BDNF expression by LIPUS stimulation . 
LIPUS Induces Activation of TrkB and Downstream Akt Signaling
The signaling pathway of BDNF/TrkB and its downstream enzymes including AKT and Erk is important in the development of synaptic plasticity and neurotrophic activity (Lonze and Ginty 2002) . To explore whether LIPUS stimulated BDNF expression in astrocytes through TrkB signaling, the activation of TrkB and its downstream Akt and Erk signaling were examined. LIPUS stimulation significantly increased TrkB phosphorylation ( Fig. 2A) and PLCγ protein expression (Fig. 2B ) at 4 h. Moreover, the Akt phosphorylation was significantly increased in a time-dependent manner following LIPUS stimulation (Fig. 2C) .
However, no significant increase in Erk1/2 phosphorylation following LIPUS stimulation was found at any of the tested time points (Fig. 2D ). These findings indicated that LIPUS provoked the activation of TrkB and its downstream Akt signaling but did not affect the Erk signaling pathway.
LIPUS Increases Intracellular Concentration of Calcium and Downstream CaMK Signaling
The expression of BDNF can be modulated by neuronal activity accompanying the influx of Ca 2+ into neurons (Bading et al. 1993; Tsuda 1996) . To test whether LIPUS would cause significant Figure 2 . Involvement of the TrkB signaling pathway in response to LIPUS stimulation in astrocytes. Astrocytes were exposed to LIPUS for 15 min. Protein levels of p-TrkB (A), PLCγ (B), p-Akt (C), and p-Erk (D) were analyzed by western blot at various time intervals after LIPUS stimulation. Note that the expression of p-TrkB, PLCγ, and p-Akt, but not p-Erk, in astrocytes was significantly increased in response to LIPUS stimulation. Data are presented as means ± SEM (n = 4). *P < 0.05; **P < 0.01 when compared with control.
increases in intracellular calcium concentration, astrocytes were exposed to LIPUS for 15 min. The increase in intracellular calcium concentration was dependent on the time following LIPUS stimulation. The intracellular calcium concentration was significantly and rapidly increased to 156% and then 229% of the controls at 1 and 2 min, respectively, after LIPUS stimulation (Fig. 3A) . Similarly, LIPUS significantly increased the protein expressions of CaMKII and CaMKIV in a time-dependent manner (Fig. 3B,C) . These results are consistent with an implication that CaMKs are promoted by increased intracellular calcium (Hansen et al. 2001 ).
Inhibition of Intracellular Concentration of Calcium and Akt Activation Blocks LIPUS-Induced BDNF Expression
To further confirm whether calcium and Akt are involved in LIPUS-induced BDNF expression, calcium chelator (BAPTA-AM) and Akt inhibitor (MK2206) were used. As shown in Fig. 4A ,B, pretreatment of astrocytes with BAPTA-AM inhibited the LIPUSinduced protein expression of CaMKII and CaMKIV. Furthermore, BAPTA-AM inhibited the protein expression of BDNF (Fig. 4C) . Furthermore, pretreatment of astrocytes with Akt inhibitor markedly reduced the LIPUS-increased Akt phosphorylation (Fig. 4D) . LIPUS-induced BDNF protein expression was also significantly reduced by pretreatment with Akt inhibitor (Fig. 4E ). Taken together, these data suggest that both increased intracellular calcium levels and Akt activation are required for the LIPUSinduced increase of BDNF expression in astrocytes.
Effects of LIPUS on CREB and NF-κB Activation
The gene transcription of BDNF can be regulated by CREB signaling (Finkbeiner et al. 1997; Lonze and Ginty 2002) . So, to determine whether LIPUS would trigger the production of BDNF via CREB, the level of CREB phosphorylation was measured. Although the Akt phosphorylation levels were increased (Fig. 2B) , we did not detect any increase in CREB phosphorylation at any time point following LIPUS stimulation (Fig. 5A) . These results suggest that CREB may not contribute to BDNF expression in astrocytes following LIPUS stimulation. To examine whether NF-κB activation is involved in the signal transduction pathway leading to BDNF expression caused by LIPUS, NF-κB p65 phosphorylation was measured and NF-κB inhibitor (QNZ) was used. LIPUS significantly elevated the phosphorylation of NF-κB p65 in a timedependent manner (Fig. 5B) . Compared with the LIPUS-alone group, pretreatment of astrocytes with QNZ significantly decreased the phosphorylation of NF-κB p65 (Fig. 5C ). QNZ abrogated the ability of LIPUS to induce BDNF protein expression, suggesting an important role of NF-κB in LIPUS-mediated BDNF expression (Fig. 5D ).
Discussion
The elevated protein levels of endogenous neurotrophic factors induced by LIPUS lend support to our hypothesis that transcranial LIPUS may be useful for neuroprotection while not requiring exogenous factors or surgical invasion . However, the molecular mechanisms by which LIPUS stimulates BDNF production in astrocytes are virtually unknown. In this study, we demonstrated that LIPUS stimulation activates TrkB and Akt signaling and increases intracellular calcium levels, resulting in the elevation of BDNF protein levels in astrocytes. TrkB is known to activate the phosphatidylinositol 3-kinase (PI3-K)/Akt, Ras/Erk, and PLC-γ signaling pathways (Yoshii and Constantine-Paton 2010) . BDNF/TrkB can induce an increase in phosphatidylinositol turnover and then elevate intracellular calcium concentrations through an activation of PLC-γ (Zirrgiebel et al. 1995) . Our immunoblotting data revealed that LIPUS stimulation significantly increased the protein expressions of phosphorylated TrkB and phosphorylated Akt and PLC-γ in astrocytes. Meanwhile, the levels of intracellular Ca 2+ were also transiently elevated by LIPUS stimulation, suggesting that the TrkB/PI3K/Akt and TrkB/PLC-γ/Ca 2+ signaling pathways are probably involved in the regulation of astrocytic function in response to LIPUS stimulation. Thus, we further examined whether the signals of Akt and intracellular Ca 2+ are involved in LIPUS-induced increases in BDNF expression. The results showed that treatment with Akt inhibitor MK2206 or calcium chelator BAPTA-AM significantly inhibited LIPUS-induced BDNF expression. Therefore, our results provide evidence that LIPUS upregulates BDNF expression in cultured astrocytes via the TrkB/PI3K/ Akt and TrkB/PLC-γ/Ca 2+ signaling pathways.
Although several transcription factors may affect the expression of various trophic factors, activation of CREB seems essential for the transcription of BDNF and c-Fos (Finkbeiner et al. 1997; Lonze and Ginty 2002) . It is almost mandatory to promote the activation of CREB for a drug to show neurotrophic effect. The activation of NF-κB signaling has also been suggested to be involved in the expression of neurotrophic factors and to play a protective role in the nervous system (Kaltschmidt et al. 2005; Saha et al. 2006) . The activation of NF-κB has been demonstrated to contribute to TNF-α-induced BDNF expression in astrocytes (Saha et al. 2006) . Moreover, the calcium/CaMK signaling pathway has been shown to play a regulatory role in NF-κB activation and BDNF production (Bading et al. 1993; Lonze and Ginty 2002; Bae et al. 2003) .
In the present study, the results indicated that LIPUS did not induce the activation of CREB, suggesting that CREB signaling is not involved in the LIPUS-induced upregulation of BDNF expression in astrocytes. We also found that LIPUS could activate calcium/ CaMK and NF-κB signals in astrocytes. Both calcium chelator and NF-κB inhibitor significantly reduced LIPUS-induced BDNF expression. These results suggest that LIPUS increases the BDNF expression in astrocytes via a calcium/CaMK-regulated NF-κB signaling pathway.
It would seem advantageous to increase BDNF levels as a means of treating several neurodegenerative diseases. However, because of the barriers associated with the administration of exogenous proteins to the CNS, it is crucial to consider the possibility that endogenous sources of trophic support exist and can be used in the injured CNS (Poduslo and Curran 1996) . Astrocytes are a common type of cell in the brain. They are important factories of molecules and may be harnessed to enhance the repair of an injured brain (Fulmer et al. 2014) . It has been reported that astrocyte-derived BDNF may be a source of trophic support that can be used to reverse deficits elicited by a brain injury (Dougherty et al. 2000; Fulmer et al. 2014) . Increasing evidence supports the use of noninvasive brain stimulation as therapeutic tools for patients with neurological and psychiatric disorders (Hummel et al. 2005; Miniussi et al. 2008) . As a therapeutic Figure 5 . Involvement of NF-κB in the potentiation of BDNF expression by LIPUS stimulation. Astrocytes were treated with LIPUS for 15 min. Cells were subjected to evaluation of p-CREB (A) and p-p65 (B) protein levels at 4, 8, 12, and 24 h after LIPUS treatment. Cells were pretreated with NF-κB inhibitor (QNZ) for 30 min, followed by stimulation with LIPUS for 15 min. NF-κB p65 phosphorylation (C) and BDNF (D) expressions were then determined 12 h after LIPUS stimulation. Data are presented as means ± SEM (n = 4). *P < 0.05; **P < 0.01 when compared with control. # P < 0.05; ## P < 0.01 when compared with the LIPUS-treated group.
approach, repetitive transcranial magnetic stimulation (rTMS) has been widely used to treat neurological diseases, such as Alzheimer's disease, Parkinson's disease, and depression (Wu et al. 2008; Schonfeldt-Lecuona et al. 2010; Guerra et al. 2011 ). It has also been shown that rTMS can alleviate cognitive dysfunction in VaD rats depending on BDNF activity (Wang et al. 2010) . In this study, we demonstrate that astrocytes react to LIPUS exposure by releasing different trophic factors, which in turn can influence neurons in the vicinity. Moreover, LIPUS is capable of stimulating intact brain circuitry and promoting levels of BDNF, an important regulator of long-term memory (Bekinschtein et al. 2008; Tufail et al. 2010) . In summary, LIPUS stimulation upregulates BDNF production in astrocytes through the activation of NF-κB via the TrkB/PI3K/ Akt and calcium/CaMK signaling pathways (Fig. 6) . The noninvasive nature of LIPUS provides many advantages in terms of practical applications. The current study already suggests the possibility that manipulation of neurotrophic factors by LIPUS might provide a new therapeutic strategy for treating neurodegenerative disorders, whether as a primary or adjunct therapy. 
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